India
· Delayed Price · Currency is INR Dr. Lal PathLabs Statistics
Total Valuation
Dr. Lal PathLabs has a market cap or net worth of INR 281.46 billion. The enterprise value is 274.86 billion.
| Market Cap | 281.46B |
| Enterprise Value | 274.86B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | Aug 20, 2024 |
Share Statistics
Dr. Lal PathLabs has 83.31 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Shares Outstanding | 83.31M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 55.56% |
| Owned by Institutions (%) | 27.84% |
| Float | 36.73M |
Valuation Ratios
The trailing PE ratio is 73.75 and the forward PE ratio is 62.26. Dr. Lal PathLabs's PEG ratio is 3.81.
| PE Ratio | 73.75 |
| Forward PE | 62.26 |
| PS Ratio | 12.28 |
| PB Ratio | 15.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | 3.81 |
Enterprise Valuation
| EV / Earnings | 72.04 |
| EV / Sales | 12.02 |
| EV / EBITDA | 43.72 |
| EV / EBIT | 55.83 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 13.10 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | n/a |
| Interest Coverage | 18.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 14.48% |
| Revenue Per Employee | 5.58M |
| Profits Per Employee | 930,800 |
| Employee Count | 4,099 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.87% in the last 52 weeks. The beta is 0.32, so Dr. Lal PathLabs's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +50.87% |
| 50-Day Moving Average | 3,128.09 |
| 200-Day Moving Average | 2,632.74 |
| Relative Strength Index (RSI) | 64.85 |
| Average Volume (20 Days) | 214,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Lal PathLabs had revenue of INR 22.88 billion and earned 3.82 billion in profits. Earnings per share was 45.81.
| Revenue | 22.88B |
| Gross Profit | 13.22B |
| Operating Income | 4.92B |
| Pretax Income | 5.38B |
| Net Income | 3.82B |
| EBITDA | 5.91B |
| EBIT | 4.92B |
| Earnings Per Share (EPS) | 45.81 |
Balance Sheet
The company has 9.43 billion in cash and 2.47 billion in debt, giving a net cash position of 6.96 billion or 83.50 per share.
| Cash & Cash Equivalents | 9.43B |
| Total Debt | 2.47B |
| Net Cash | 6.96B |
| Net Cash Per Share | 83.50 |
| Equity (Book Value) | 18.85B |
| Book Value Per Share | 222.23 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.78%, with operating and profit margins of 21.52% and 16.68%.
| Gross Margin | 57.78% |
| Operating Margin | 21.52% |
| Pretax Margin | 23.51% |
| Profit Margin | 16.68% |
| EBITDA Margin | 25.83% |
| EBIT Margin | 21.52% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.71%.
| Dividend Per Share | 24.00 |
| Dividend Yield | 0.71% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.60% |
| Earnings Yield | 1.36% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |